Smoking is returning to the corners of San Francisco, the AI epicenter. Earlier this month, Palantir Chief Technology Officer Shyam Sankar told Face the Nation that some young AI researchers are taking up cigarettes to demonstrate complete confidence that artificial intelligence will cure cancer.

The concept also surfaced in a Business Insider piece about young founders who are using smoke breaks to network. One founder reasoned that AI will cure lung cancer before he develops it.

Call it ‘Cig’ Tech

In the tech sector, stepping onto a balcony during a coffee break now double-functions as an expression of faith in technology.

As a former smoker who spent decades successfully betting on emerging technology, I understand the psychological appeal. Still, what zealot tech enthusiasts are wagering in this particular practice ignores the basic odds that smoking kills.

Consider one of their arguments: AI will cure cancer, so it’s fine to smoke now.

In longevity circles, the name for this kind of thinking is escape velocity — the point at which medical progress adds more than a year of life expectancy for every year that passes. The cigarette-on-the-balcony crowd is making a private bet that they'll hit it before their lungs or arteries give out.

But it's more complicated than that.

First, cancer includes hundreds of distinct diseases, so the idea of one single cure isn’t even possible yet. What AI is doing to support that ‘cure’ is legitimate, but it’s still early. 

About 170 AI-designed drug programs reached human trials by early 2026—up from two dozen in 2023. Yet none have won full FDA approval, and the closest AI-designed cancer candidate targets a lung-scarring disease rather than tumors.

AI-designed drugs fail in mid-stage clinical trials at roughly the same rate as conventional treatments. While AI accelerates early-stage research, it has not yet improved late-stage success rates.

Because AI provides better early detection and more effective treatments, cancer outcomes are still improving, though. The American Cancer Society reported in January that five-year survival across all cancers reached 70%, while lung cancer survival nearly doubled since the mid-1990s. It’s now at 28%.

Cigarette smokers should not be fooled by this good news. Cancer accounts for only about a third of smoking-related deaths. Most stem from heart attacks, strokes, and emphysema.

An oncology breakthrough will not repair damaged coronary arteries or lungs degraded by decades of exposure to cigarette smoke.

A University of Toronto study of 1.5 million adults showed that smokers aged 40 to 79 die at nearly 3x the rate of non-smokers, losing 12 to 13 years of life expectancy—primarily due to cardiovascular damage.

The timing is straightforward. In this study, individuals who quit before age 40 achieve near-normal life expectancy. (However, quitting at any age makes it more likely you’ll survive to the same age as non-smokers within ten years).

Research led by Prabhat Jha adds that quitting by age 30 eliminates virtually all excess risk, while quitting between 45 and 54 reclaims about six years of life.

A 25-year-old smoking on a balcony is not truly gambling on AI, because their young body would forgive them for smoking if they quit early enough. The real gamble would be whether they can actually quit once they start.

If you want to show faith in AI, find a new way to do it 

At 73, I have watched promised medical cures arrive late or incomplete. While I cover longevity science and expect AI to accelerate progress, reliable life extension still relies on fundamental habits: avoiding smoking, staying active, prioritizing sleep, and seeing doctors regularly. Relying on future medical advances is a poor substitute for proven, accessible habits you can do now.

If you want to show your faith in AI, there are better ways to do it. Stop lighting the cigarette and try to live long enough to see what else you can build with it.

Footnote: Of course, there are extremes to the AI possibilities debate. Nate Soares, the president of the Machine Intelligence Research Institute, said he’s stopped contributing to his 401(k) because he thinks AI may kill us within a decade.

The Livelong Women’s Health Summit™ will transform your mind, body, and confidence. Come for tools, insights, and strategies to live healthier and longer.

How did you enjoy today's newsletter?

Was this newsletter useful? Do you have any ideas for future discussion? Fill out the poll or respond to this email.

Login or Subscribe to participate

The information provided about wellness and health is for general informational and educational purposes only. We are not licensed medical professionals, and the content here should not be considered medical advice. Talk to a doctor before trying any of these suggestions.

Reply

Avatar

or to participate